Challenge of rechallenge: When to resume immunotherapy following an immune-related adverse event

Erica C. Nakajima, Evan J. Lipson, Julie R. Brahmer

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Challenge of rechallenge: When to resume immunotherapy following an immune-related adverse event'. Together they form a unique fingerprint.

Medicine & Life Sciences